What is the Therapy-Disability-Neurology (TDN) grade?

The Therapy-Disability-Neurology (TDN) grade is a structured way to describe how serious a neurosurgical adverse event (AE) is. Unlike systems that look almost only at what was done to treat the complication, TDN explicitly adds two patient-centered dimensions: how much day-to-day function is affected (disability) and whether there is a new neurologic deficit. Each AE receives a short code such as T3D2N2, where T is therapy, D disability, and N neurology, plus a single overall TDN grade from 1 to 5 for summaries and analysis.

The framework was introduced to reduce the mismatch seen with therapy-only scales, where a devastating but hard-to-“treat” neurologic injury could be labeled as a low grade because management was minimal. TDN is intended for registry work, morbidity conferences, quality improvement, and research where consistent AE reporting matters.

Why three dimensions?

Neurosurgical complications vary along several axes at once. One patient may need a return to the operating room for a superficial wound infection but recover neurologically intact; another may have no further operation yet be left with hemiparesis. TDN separates these aspects so that severity is not collapsed into a single misleading label.

• Therapy (T) captures resource use and escalation of care in a way that parallels the familiar Clavien-Dindo ladder and neurosurgical adaptations such as the Landriel-Ibañez classification.
• Disability (D) captures functional impact using anchors related to the modified Rankin Scale (mRS), emphasizing change attributable to the AE compared with the preoperative baseline.
• Neurology (N) records whether the AE caused any new neurologic deficit, including deficits that cause distress or clinical importance even when mRS-style disability appears modest.

Therapy dimension (T1–T5)

Assign T based on the most intensive level of management required specifically because of the AE (not routine expected care). The levels align conceptually with Clavien-Dindo grades I through V.

• T1 — Care limited to supportive or minor measures such as antiemetics, antipyretics, analgesics, diuretics, electrolyte correction, or bedside management of a superficial wound issue without pharmacologic escalation beyond that band.
• T2 — Requires pharmacologic treatment beyond that minimal set, blood transfusion, or total parenteral nutrition.
• T3 — Requires an invasive intervention: reoperation, endoscopic procedure, interventional radiology, or other procedural management.
• T4 — Life-threatening instability or organ failure attributable to the AE, with need for intensive care–level support.
• T5 — Death attributed to the AE.

In practice, teams document the highest therapy level that honestly reflects what the complication demanded, including transfers, ICU stays, and unplanned procedures.

Disability dimension (D1–D5)

D should reflect functional status after the AE relative to preoperative function. The intent is not to restage the patient in the abstract but to score incremental harm from the complication.

• D1 — Corresponds to little or no meaningful restriction in daily life (mRS-style scores in the 0–1 range): no symptoms or only slight symptoms without significant limitation of usual activities.
• D2 — Clear limitation of activities of daily living but still some independence in broader terms (mRS-style 2–3): the patient is noticeably disabled yet not bedbound.
• D3 — Severe disability: unable to walk unaided or attend to bodily needs without assistance (mRS-style 4).
• D4 — Bedridden, in need of constant help, often with incontinence (mRS-style 5).
• D5 — Death (mRS-style 6).

When baseline mRS was already elevated, raters focus on worsening clearly tied to the AE rather than labeling chronic baseline impairment as a new D level without a causal link.

Neurology dimension (N1–N2)

This dimension is deliberately compact:

• N1 — No new neurologic deficit attributable to the AE.
• N2 — At least one new neurologic deficit attributable to the AE (motor, sensory, speech, vision, cranial nerve, cognitive, seizure disorder as a new problem, etc.).

It exists because some neurologic injuries are clinically significant—facial weakness, partial field cut, subtle cognitive change—yet may not move mRS as much as motor paralysis does. N2 flags neurologic morbidity even when D stays lower.

Overall TDN grade from the calculator

After you choose T, D, and N, the overall TDN grade is the maximum of the three numeric subscripts. Intuitively, the worst of the three dimensions sets the headline severity.

Examples:

• T2D1N1 → overall 2 (therapy is the highest dimension).
• T1D3N2 → overall 3 (disability dominates).
• T3D4N1 → overall 4 (severe disability outranks invasive therapy and absent new deficit in this example).
• T1D1N2 → overall 2 (a new deficit alone can raise the composite grade to 2).

Grade 5 and the T5D5N2 convention

Whenever an AE is fatal, the TDN system treats it as the highest severity. By convention, such events are written T5D5N2 and the overall grade is 5, even if one were tempted to leave other dimensions unspecified. This keeps mortality reporting uniform across centers and datasets.

Non-fatal AEs should be reported with the actual triple that reflects therapy, disability, and neurology; the calculator shows both your selected triple and the suggested reporting string, upgrading to T5D5N2 when T5 or D5 applies.

How clinicians typically use TDN in documentation

Many groups report both the overall number and the full T–D–N vector, because the overall grade supports benchmarking while the components explain why an event was severe. For morbidity and mortality review, separating a “high-therapy, low-disability” event from a “low-therapy, high-disability” event clarifies where processes broke down and which outcomes were harmed.

TDN is not a substitute for a full narrative operative note, discharge summary, or root-cause analysis. It is a standardized overlay that makes complication severity more comparable across procedures, surgeons, and hospitals.

Practical tips for consistent rating

• Anchor to preoperative status for D and N so chronic deficits are not double-counted.
• Use the highest truthful level per dimension; when uncertain between adjacent grades, document the reasoning in free text elsewhere in the record.
• Time window: apply grades for the AE episode you are classifying (e.g., index admission vs defined postoperative follow-up), and keep that window consistent within a study or registry.
• Multifocal complications: rate the composite AE you are reporting; if multiple distinct AEs occur, each may receive its own TDN assignment.

Relationship to older neurosurgical complication schemes

TDN does not replace every legacy system overnight. It is designed to coexist with quality metrics that still expect Clavien-Dindo–style therapy grades, while adding disability and neurology that those systems under-emphasize. Researchers comparing eras or institutions should state explicitly whether they report overall TDN, each dimension separately, or both.

Limitations and appropriate use

Like all grading tools, TDN depends on accurate clinical information and shared definitions within a team. Borderline cases—electrolyte disturbances, device-related issues without neurologic change, or subjective cognitive symptoms—can split raters unless local examples are discussed. The calculator encodes the published arithmetic (maximum of dimensions; fatal events as T5D5N2) but does not verify that the underlying clinical facts are correct or that an event truly meets each definition.

TDN is intended for professional documentation, quality reporting, and education. It does not establish medicolegal causation, billing codes, or individual treatment decisions.